{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:59:20Z","timestamp":1790913560062,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":194,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003827","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101326","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:59:21Z","timestamp":1784753961000},"page":"101326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Systemic immune-inflammation index as a prognostic marker in pancreatic ductal adenocarcinoma: a metaanalysis"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7738-4846","authenticated-orcid":false,"given":"Bence","family":"Pachinger-Moln\u00e1r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ot\u00edlia","family":"Menyh\u00e1rt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctarc.2026.101326_bib0001","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel Mph","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101326_bib0002","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated projection of US cancer incidence and death to 2040","volume":"4","author":"Rahib","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"10485","key":"10.1016\/j.ctarc.2026.101326_bib0003","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101326_bib0004","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/MPA.0000000000000368","article-title":"Early detection of sporadic pancreatic cancer: summative review","volume":"44","author":"Chari","year":"2015","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101326_bib0005","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000463","article-title":"Chronic pancreatitis is a risk factor for pancreatic cancer, and incidence increases with duration of disease: a systematic review and metaanalysis","volume":"13","author":"Gandhi","year":"2022","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101326_bib0006","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-017-0551-7","article-title":"Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions","volume":"11","author":"Zhang","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101326_bib0009","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41571-023-00746-1","article-title":"Neoadjuvant therapy for pancreatic cancer","volume":"20","author":"Springfeld","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101326_bib0044","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ejso.2022.12.006","article-title":"Immunonutrition and prehabilitation in pancreatic cancer surgery: a new concept in the era of ERAS and neoadjuvant treatment","volume":"49","author":"De Luca","year":"2023","journal-title":"Eur. J. Surg. Oncol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101326_bib0045","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.3390\/cancers14102429","article-title":"Immunotherapy in pancreatic cancer: why do we keep failing? A focus on tumor immune microenvironment, predictive biomarkers and treatment outcomes","volume":"14","author":"Di Federico","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101326_bib0046","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3390\/ph14070677","article-title":"Hacking pancreatic cancer: present and future of personalized medicine","volume":"14","author":"Di Federico","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101326_bib0047","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71746-z","article-title":"Sex differences in adverse events among cancer patients receiving immune checkpoint inhibitors: the MOUSEION-07 systematic review and metaanalysis","volume":"14","author":"Vitale","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101326_bib0048","doi-asserted-by":"crossref","DOI":"10.1007\/s10555-026-10327-0","article-title":"Hyponatremia in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-014 metaanalysis","volume":"45","author":"Vitale","year":"2026","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ctarc.2026.101326_bib0049","doi-asserted-by":"crossref","first-page":"11107","DOI":"10.2147\/DDDT.S560518","article-title":"Infusion-related reactions among cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-013 Systematic review and metaanalysis","volume":"Volume 19","author":"Vitale","year":"2025","journal-title":"Drug Des. Devel. Ther."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101326_bib0010","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-07182-9","article-title":"Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma","volume":"20","author":"Pointer","year":"2020","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101326_bib0011","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.surg.2016.04.039","article-title":"Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma","volume":"160","author":"Glazer","year":"2016","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101326_bib0012","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s11605-019-04187-z","article-title":"Systemic immune-inflammation index (SII) predicts poor survival in pancreatic cancer patients undergoing resection","volume":"24","author":"Jomrich","year":"2020","journal-title":"J. Gastrointest. Surg."},{"issue":"23","key":"10.1016\/j.ctarc.2026.101326_bib0013","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"23","key":"10.1016\/j.ctarc.2026.101326_bib0014","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101326_bib0015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1620\/tjem.236.297","article-title":"Systemic immune-inflammation index, based on platelet counts and neutrophil-lymphocyte ratio, is useful for predicting prognosis in small cell lung cancer","volume":"236","author":"Hong","year":"2015","journal-title":"Tohoku J. Exp. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101326_bib0016","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-017-1326-1","article-title":"Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer","volume":"15","author":"Tong","year":"2017","journal-title":"J. Transl. Med."},{"issue":"34","key":"10.1016\/j.ctarc.2026.101326_bib0017","doi-asserted-by":"crossref","first-page":"54564","DOI":"10.18632\/oncotarget.10515","article-title":"Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib","volume":"7","author":"Lolli","year":"2016","journal-title":"Oncotarget"},{"issue":"OCT","key":"10.1016\/j.ctarc.2026.101326_bib0018","article-title":"Systemic immune-inflammation index predicts the clinical outcome in patients with mCRPC treated with Abiraterone","volume":"7","author":"Lolli","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101326_bib0019","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2024.12410","article-title":"Systemic immune inflammation index and gastric cancer prognosis: a systematic review and meta-analysis","volume":"27","author":"Yang","year":"2024","journal-title":"Exp. Ther. Med."},{"issue":"43","key":"10.1016\/j.ctarc.2026.101326_bib0020","doi-asserted-by":"crossref","first-page":"75381","DOI":"10.18632\/oncotarget.18856","article-title":"Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and metaanalysis","volume":"8","author":"Zhong","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctarc.2026.101326_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.915599","article-title":"Prognostic significance of the systemic immune inflammation index in patients with metastatic and unresectable pancreatic cancer","volume":"9","author":"Han","year":"2022","journal-title":"Front. Surg."},{"issue":"15","key":"10.1016\/j.ctarc.2026.101326_bib0022","doi-asserted-by":"crossref","first-page":"8441","DOI":"10.3390\/ijms25158441","article-title":"Inflammation and colorectal cancer: a metaanalysis of the prognostic significance of the Systemic Immune\u2013Inflammation Index (SII) and the Systemic Inflammation Response Index (SIRI)","volume":"25","author":"Menyhart","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101326_bib0023","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s11605-019-04187-z","article-title":"Systemic immune-inflammation index (SII) predicts poor survival in pancreatic cancer patients undergoing resection","volume":"24","author":"Jomrich","year":"2020","journal-title":"J. Gastrointest. Surg."},{"issue":"16","key":"10.1016\/j.ctarc.2026.101326_bib0024","doi-asserted-by":"crossref","first-page":"20585","DOI":"10.18632\/aging.203449","article-title":"Prognostic and clinicopathological significance of systemic immune-inflammation index in pancreatic cancer: a metaanalysis of 2365 patients","volume":"13","author":"Shui","year":"2021","journal-title":"Aging"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101326_bib0027","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1080\/03007995.2023.2239033","article-title":"The prognostic effect of the systemic immune-inflammation index on overall survival of periampullary cancer","volume":"39","author":"Yur","year":"2023","journal-title":"Curr. Med. Res. Opin."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101326_bib0025","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a metaanalysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101326_bib0026","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12967-019-1782-x","article-title":"Systemic immune-inflammation index predicts prognosis of patients with advanced pancreatic cancer","volume":"17","author":"Zhang","year":"2019","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101326_bib0028","first-page":"206","article-title":"Predictive value of the systemic immune inflammatory index on the overall survival rate of patients after Whipple surgery for pancreatic ductal adenocarcinoma","volume":"27","author":"Xu","year":"2021","journal-title":"Chin. J. Hepatob. Surg."},{"key":"10.1016\/j.ctarc.2026.101326_bib0029","doi-asserted-by":"crossref","DOI":"10.1177\/11795549241298552","article-title":"High systemic immune-inflammation index values before treatment predict poor pancreatic cancer outcomes after definitive chemoradiotherapy","volume":"18","author":"Topkan","year":"2024","journal-title":"Clin. Med. Insights Oncol."},{"key":"10.1016\/j.ctarc.2026.101326_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.585271","article-title":"Systemic immune-inflammation index and changes of neutrophil-lymphocyte ratio as prognostic biomarkers for patients with pancreatic cancer treated with immune checkpoint blockade","volume":"11","author":"Shang","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101326_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-022-02606-1","article-title":"The role of systemic immuno-inflammatory factors in resectable pancreatic adenocarcinoma: a cohort retrospective study","volume":"20","author":"Schlanger","year":"2022","journal-title":"World J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101326_bib0032","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1245\/s10434-019-08094-0","article-title":"Prognostic value of the systemic immune-inflammation index (SII) after neoadjuvant therapy for patients with resected pancreatic cancer","volume":"27","author":"Murthy","year":"2020","journal-title":"Ann. Surg. Oncol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101326_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100818","article-title":"Analysis of the efficacy, safety and survival factors of stereotactic body radiation therapy in patients with recurrence of pancreatic cancer","volume":"13","author":"Li","year":"2020","journal-title":"Transl. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101326_bib0034","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s11605-019-04187-z","article-title":"Systemic immune-inflammation index (SII) predicts poor survival in pancreatic cancer patients undergoing resection","volume":"24","author":"Jomrich","year":"2020","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.ctarc.2026.101326_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.915599","article-title":"Prognostic significance of the systemic immune inflammation index in patients with metastatic and unresectable pancreatic cancer","volume":"9","author":"Han","year":"2022","journal-title":"Front. Surg."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101326_bib0036","doi-asserted-by":"crossref","first-page":"251","DOI":"10.21037\/atm-20-3499","article-title":"Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer","volume":"9","author":"Bittoni","year":"2021","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101326_bib0037","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/SLA.0000000000002660","article-title":"The systemic-immune-inflammation index independently predicts survival and recurrence in resectable pancreatic cancer and its prognostic value depends on bilirubin levels: a retrospective multicenter cohort study","volume":"270","author":"Aziz","year":"2019","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ctarc.2026.101326_bib0038","article-title":"Prognostic and recurrent significance of SII in patients with pancreatic head cancer undergoing pancreaticoduodenectomy","volume":"13","author":"Chen","year":"2023","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101326_bib0039","first-page":"1","article-title":"Nomogram for prognosis prediction in metastatic pancreatic cancer patients undergoing intra-arterial infusion chemotherapy: incorporating immune-inflammation scores and coagulation indicators","volume":"25","author":"Yang","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctarc.2026.101326_bib0040","first-page":"36","article-title":"In patients with metastatic pancreas cancers, evaluation of the relationship between neutrophil lymphocide ratio, trombocyte index, systemic Immune-inflamation index and clinical, pathologic and prognostic factors","author":"Merve Kuday \u00d6zkan","year":"2025","journal-title":"Euras. J. Med. Invest."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101326_bib0042","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.5306\/wjco.v15.i8.1021","article-title":"Performance of nutritional and inflammatory markers in patients with pancreatic cancer","volume":"15","author":"Lu","year":"2024","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101326_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1622821","article-title":"A novel model for predicting prognosis in pancreatic cancer patients: a retrospective study","volume":"15","author":"Jiang","year":"2025","journal-title":"Front. Oncol."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:50:24Z","timestamp":1790913024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226002376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":46,"alternative-id":["S2468294226002376"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101326","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic immune-inflammation index as a prognostic marker in pancreatic ductal adenocarcinoma: a metaanalysis","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101326"}}